Global 3D Bioprinted Human Tissue Market Report and Forecast 2025-2034

3D Bioprinted Human Tissue: Introduction

3D bioprinted human tissues are artificially manufactured functional tissues that mimic the function and architecture of native tissues. They are developed using layer-by-layer deposition of living cells, growth factors and biomaterials. 3D bioprinted human tissues are widely used in regenerative medicine providing the potential for creating organs and personalized tissues for transplantation along with drug discovery, research, and cosmetic surgeries, among others.

Global 3D Bioprinted Human Tissue Market Analysis

The 3D bioprinted human tissue market demand has grown significantly in recent years owing to its increasing application in replacing human tissues, creating biomaterial skin for wounds, skin grafting and printing living skin with blood vessels.

With rising technical advancements in biotechnology, the researchers aim at offering better techniques for quality tissue development. Digital light processing (DLP) 3D bioprinting, developed by the University of California research team is one of the latest methods used for creating a vascularized tissue that operates as a human-like living cell with biomaterial structures. There is significant development in bioinks as well, wherein HU3DINKS project has been launched by BIO INX to replace animal based bioink with human bioink is a key area of attention.

3D bioprinted human tissues showcase commercial adaptability, high experimental reproducibility, as well as industrial scalability. Consequently, it is a major area of interest amongst investors. In July 2023, 3D BioFibR, a Canadian tissue engineering company, received a USD 3.52 million funding to expand the company’s profile and develop diameter-controlled collagen fibers at a commercial scale. Such investments demonstrate that the 3D bioprinted human tissue market growth is anticipated to witness further growth in upcoming years.

Global 3D Bioprinted Human Tissue Market Segmentation

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Global 3D Bioprinted Human Tissue Market Overview

North America, led by the United States and Canada, is anticipated to lead the 3D bioprinted human tissue market share. The market is primarily driven by rising government initiatives and investments to foster innovation in biotechnology research. In March 2023, the Government of Canada invested approximately USD 25.7 million in Aspect Biosystems, a coming-of-age biotechnology firm.

Europe is another significant player in the market with numerous academic institutions and biotechnology companies at home. The market growth can be attributed to increasing partnerships between prominent companies and institutes to develop advanced developments in the field.

Owing to the presence of economic resources and high percentage of academically talented youth, the Asia Pacific 3D bioprinted human tissue market value is projected to grow further in the forecast period. Apart from foreign investments, the government of emerging economies such as India, South Korea, and Taiwan are taking critical initiatives aimed at improving the healthcare and research infrastructure.

Global 3D Bioprinted Human Tissue Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• 3D Systems, Inc.
• Materialise NV
• Oceanz 3D printing
• Organovo
• Prellis Biologics
• SOLS Systems
• Stratasys Ltd
• The Pexion Group
• Allevi, Inc.
• Aspect Biosystems Ltd.
• Biolife 4D
• Cellbricks
• Cellink
• Microdrop
• MicroFab Technologies Inc.

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.